12 Month Price Forecast For EHC
Distance to EHC Price Forecasts
EHC Price Momentum
๐ค Considering Encompass Health (EHC)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 6:53 AM UTC
EHC Analyst Ratings & Price Targets
Based on our analysis of 19 Wall Street analysts, EHC has a bullish consensus with a median price target of $118.00 (ranging from $110.00 to $125.00). The overall analyst rating is Strong Buy (9.7/10). Currently trading at $98.63, the median forecast implies a 19.6% upside. This outlook is supported by 13 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Ben Hendrix at RBC Capital, suggesting a 11.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
EHC Analyst Consensus
EHC Price Target Range
Latest EHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for EHC.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Feb 10, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $120.00 |
Feb 7, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $118.00 |
Oct 30, 2024 | Truist Securities | David Macdonald | Buy | Reiterates | $116.00 |
Oct 30, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $110.00 |
Oct 29, 2024 | Keybanc | Matthew Gillmor | Overweight | Maintains | $117.00 |
Oct 29, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $116.00 |
Oct 14, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $108.00 |
Oct 11, 2024 | Keybanc | Matthew Gillmor | Overweight | Initiates | $115.00 |
Sep 26, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $105.00 |
Sep 25, 2024 | UBS | Andrew Mok | Buy | Maintains | $110.00 |
Aug 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $104.00 |
Aug 8, 2024 | UBS | Andrew Mok | Buy | Maintains | $100.00 |
Aug 6, 2024 | Stephens & Co. | Scott Fidel | Overweight | Reiterates | $105.00 |
Aug 6, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $109.00 |
Jul 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $100.00 |
Jul 10, 2024 | Leerink Partners | Whit Mayo | Outperform | Initiates | $100.00 |
Jul 10, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $113.00 |
Jun 5, 2024 | Stephens & Co. | Scott Fidel | Overweight | Reiterates | $94.00 |
May 22, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $95.00 |
Apr 26, 2024 | Raymond James | John Ransom | Strong Buy | Reiterates | $95.00 |
Stocks Similar to Encompass Health Corp
The following stocks are similar to Encompass Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Encompass Health Corp (EHC) Financial Data
Encompass Health Corp has a market capitalization of $10.02B with a P/E ratio of 22.2x. The company generates $5.22B in trailing twelve-month revenue with a 8.1% profit margin.
Revenue growth is +11.9% quarter-over-quarter, while maintaining an operating margin of +15.5% and return on equity of +22.9%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Encompass Health Corp (EHC) Company Overview
About Encompass Health Corp
Provides post-acute healthcare services.
The company operates inpatient rehabilitation hospitals that deliver specialized medical, nursing, therapy, and ancillary services to patients recovering from physical or cognitive disabilities. It generates revenue primarily through the Medicare program, managed care plans, private insurers, and state governments, ensuring a diversified income stream from various healthcare payers.
Encompass Health Corporation, formerly known as HealthSouth Corporation, has been operating since 1984 and is headquartered in Birmingham, Alabama. Its focus on rehabilitation services positions it well within the healthcare sector, catering to a growing demand for post-acute care solutions.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
27,481
CEO
Mr. Mark J. Tarr
Country
United States
IPO Year
2017
Website
www.encompasshealth.comEncompass Health Corp (EHC) Latest News & Analysis
Encompass Health Corporation will hold its Q4 2024 Earnings Conference Call on February 7, 2024, at 10:00 AM ET, featuring key executives and several financial analysts.
The earnings call provides insights into Encompass Health's financial performance, informing market expectations and influencing stock valuations, crucial for investment decisions.
Encompass Health Corporation (NYSE: EHC) announced Q4 2024 operational results on February 6, 2025. Further details on financial performance were not included in the excerpt.
Encompass Health's Q4 2024 results can impact stock performance, indicating financial health, growth potential, and operational efficiency, which are critical for investment decisions.
Encompass Health (EHC) reported Q3 earnings of $1.17 per share, surpassing estimates of $1.02 and up from $0.95 per share year-over-year.
Encompass Health's stronger-than-expected earnings indicate robust financial health and growth, potentially boosting investor confidence and stock performance.
Encompass Health (EHC) reported its revenue and EPS for Q4 2024, highlighting the need to compare these figures with Wall Street estimates and previous year's performance.
Comparison of Encompass Health's revenue and EPS against Wall Street estimates and prior year figures can indicate growth trends and market performance, influencing stock valuation and investor sentiment.
Encompass Health Named One of Fortune's World's Most Admired Companies for Fifth Consecutive Year
6 days agoEncompass Health Corp. (NYSE: EHC) has been recognized in Fortune's 2025 World's Most Admired Companies list, highlighting its status in the rehabilitation hospital sector.
Encompass Health's inclusion in Fortune's Most Admired Companies enhances its reputation, potentially attracting investors and boosting stock performance due to increased confidence in its management and operations.
Encompass Health (EHC) is expected to report its Q4 2024 performance, with a focus on key metrics beyond traditional revenue and earnings estimates for deeper analysis.
Analyzing Encompass Health's performance beyond traditional estimates can reveal underlying growth trends and operational efficiencies, influencing investment decisions and stock valuation.
Frequently Asked Questions About EHC Stock
What is Encompass Health Corp's (EHC) stock forecast for 2025?
Based on our analysis of 19 Wall Street analysts, Encompass Health Corp (EHC) has a median price target of $118.00. The highest price target is $125.00 and the lowest is $110.00.
Is EHC stock a good investment in 2025?
According to current analyst ratings, EHC has 13 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $98.63. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for EHC stock?
Wall Street analysts predict EHC stock could reach $118.00 in the next 12 months. This represents a 19.6% increase from the current price of $98.63. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Encompass Health Corp's business model?
The company operates inpatient rehabilitation hospitals that deliver specialized medical, nursing, therapy, and ancillary services to patients recovering from physical or cognitive disabilities. It generates revenue primarily through the Medicare program, managed care plans, private insurers, and state governments, ensuring a diversified income stream from various healthcare payers.
What is the highest forecasted price for EHC Encompass Health Corp?
The highest price target for EHC is $125.00 from at , which represents a 26.7% increase from the current price of $98.63.
What is the lowest forecasted price for EHC Encompass Health Corp?
The lowest price target for EHC is $110.00 from Ben Hendrix at RBC Capital, which represents a 11.5% increase from the current price of $98.63.
What is the overall EHC consensus from analysts for Encompass Health Corp?
The overall analyst consensus for EHC is bullish. Out of 19 Wall Street analysts, 13 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $118.00.
How accurate are EHC stock price projections?
Stock price projections, including those for Encompass Health Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.